Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 9, 2018 · 10-Q · 39 days after period end · 0001564590-18-012461
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$3.02M | -$205.00K | -$242.00K | -$4.52M |
| EPS Diluted | -$2.43 | -$96.56 | -$11.40 | $0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end
